Current and Future Applications of Immunological Attenuation via Pegylation of Cells and Tissue

ISSN： 1173-8804

Source： BioDrugs, Vol.15, Iss.12, 2001-01, pp. : 833-847

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Therapeutic Applications of Mesenchymal Stem Cells: Current Outlook

By Boregowda Siddaraju V. Phinney Donald G.

BioDrugs, Vol. 26, Iss. 4, 2012-08 ,pp. : 201-208

Adis International

Access to resources Recommend Favorite

Site-Specific PEGylation of Therapeutic Proteins via Optimization of Both Accessible Reactive Amino Acid Residues and PEG Derivatives

By Zhang Chun Yang Xiao-lan Yuan Yong-hua Pu Jun Liao Fei

BioDrugs, Vol. 26, Iss. 4, 2012-08 ,pp. : 209-215

Adis International

Access to resources Recommend Favorite

Teledermatology: Current Status and Future Directions

By Whited J.D.

American Journal of Clinical Dermatology, Vol. 2, Iss. 2, 2001-02 ,pp. : 59-64

Adis International

Access to resources Recommend Favorite

The Impact of PEGylation on Biological Therapies

By Veronese Francesco M. Mero Anna

BioDrugs, Vol. 22, Iss. 5, 2008-01 ,pp. : 315-329

Adis International

Access to resources Recommend Favorite

Non infectious and non immunological side effects of red blood cells transfusions

By Mercat A.

Reanimation, Vol. 12, Iss. 8, 2003-12 ,pp. : 575-579

Elsevier

Access to resources Recommend Favorite